Analgesic clinical trials failing to assess movement-evoked postoperative pain
Editor's Note Most surgical studies still do not report movement-evoked postoperative pain despite the recommendations of expert consensus groups, according to findings published November 27 in Anesthesiology. Researchers came to essentially the same conclusion upon re-evaluating the assessment of pain at rest and movement-evoked pain in 2011. In this updated…
Study: Intrathecal morphine reduces post-op opioid need in open prostate, kidney surgeries
Editor's Note A recent study suggests a single dose of intrathecal morphine provides long-lasting analgesia and reduces the need for postoperative systemic administration of opioids after painful open urological procedures. The Journal of PeriAnesthesia Nursing published the data January 31. Intrathecal opioid administration is an attractive technique in these surgeries…
How mentors help nurses transition to advanced practice roles
Editor's Note This article by nurse researchers at Washington University in St Louis and University of Arkansas in Fayetteville, shows how mentorship can positively affect role transitioning from an experienced RN to a novice acute care nurse practitioner (ACNP) in a cardiothoracic ICU. The authors note the differences between preceptors,…
Free Daily News
- Hospital margins improve as outpatient revenue accelerates, but costs loom
- Breast cancer surgery delays tied to higher upstaging, faster tumor growth
- Exercise programs ease stress and burnout for nurses, review finds
- WHO and robotic surgery society partner to expand global access to telesurgery
- Health systems lean toward established partners for AI adoption
- Immigration raids are driving patients back to telehealth and ERs
- Study: Global access to surgery deemed a crisis, leaves 160 million without care
- Large-scale studies link preoperative cognition to delirium risk, reveal its deadly toll after surgery
- Socioeconomic deprivation linked to lower fitness before surgery, UK study finds
- Perioperative medication decisions need individualized risk-benefit approach